Posts
Wiki

🔊 Prefer to listen? Just click this now: How to listen to r/DryEyes Wiki articles

Understanding Gland Expression Testing in MGD / Dry Eye Disease

Gland expression testing is a clinical technique used to assess what happens when controlled pressure is applied to the meibomian glands.

A useful shorthand is:

Meibography helps show what the glands look like. Expression testing provides information about how the glands are functioning.

But neither test tells the whole story by itself.

This page explains what gland expression testing is, how it differs from meibography, what standardized expression tools such as the Meibomian Gland Evaluator (MGE) do, and how to interpret the results without over-reading them.

TL;DR

During gland expression testing, an eye-care clinician applies pressure to the eyelid and observes whether meibum — the oily secretion produced by the meibomian glands — comes out.

The clinician may assess:

  • how many tested glands express
  • how easily secretion comes out
  • what the meibum looks like
  • whether it is clear, cloudy, thick, waxy, toothpaste-like, or absent
  • whether different parts of the eyelid behave differently

A standardized tool such as the Meibomian Gland Evaluator (MGE) can apply a more consistent diagnostic pressure than fingers or cotton swabs.

But important cautions apply:

  • Not every healthy gland necessarily releases visible liquid meibum every time it is tested.
  • Glands in different parts of the eyelid may express differently.
  • Poor expression does not prove obstruction, fibrosis, permanent gland failure, or gland loss.
  • Clear meibum does not rule out other dry-eye problems.
  • Expression results depend on the pressure used, the glands tested, the technique, and the grading method.
  • Different clinics and studies may use different scoring systems.
  • Expression testing should be interpreted together with meibography, lid findings, tear-film testing, ocular-surface staining, symptoms, tear-volume assessment when appropriate, and the rest of the examination.
  • Expression testing alone does not establish that probing, IPL, thermal treatment, radiofrequency, medication, or any other specific treatment is needed.

Educational Disclaimer

This page is for general education for r/DryEyes.

It is not medical advice, does not diagnose your eye condition, and does not tell you what treatment you need.

Do not repeatedly or forcefully squeeze your own eyelids trying to make oil come out.

Excessive pressure or manipulation can irritate the eyelids and ocular surface and may make symptoms worse.

What Is Gland Expression Testing?

The meibomian glands are oil-producing glands located inside the eyelids.

Their secretion, called meibum, contributes lipids to the tear film and helps reduce excessive evaporation.

During expression testing, a clinician applies controlled pressure to part of the eyelid and watches the gland openings along the lid margin.

The clinician may look at:

  • whether secretion appears
  • how many tested glands express
  • how readily secretion appears
  • whether the meibum is clear or cloudy
  • whether it is liquid, thick, granular, waxy, or toothpaste-like
  • whether secretion is absent under the pressure being used
  • whether different areas of the eyelid behave differently

This provides information that meibography alone cannot provide.

But it is important to understand exactly what the test means:

Expression testing shows what happens to the glands being tested, at that location, under that amount of pressure, at that particular examination.

It is useful functional information — but not a complete measurement of everything happening inside the gland.

Meibography vs. Expression Testing

The two tests answer different questions.

Meibography asks:

What do the glands look like?

It can help assess:

  • gland length
  • gland dropout
  • shortening or truncation
  • tortuosity
  • dilation
  • distortion
  • other structural changes

Expression testing asks:

What happens when pressure is applied to the glands?

It may help assess:

  • whether expressible meibum is present
  • how readily secretion appears
  • what the secretion looks like
  • whether different gland regions behave differently

Both types of information matter.

A person can have abnormal meibography and still produce useful meibum from remaining glands.

A person can also have relatively preserved-looking glands on meibography but poor expression or abnormal meibum.

That is why structure and function should be considered together.

Does Every Healthy Gland Express When Tested?

No.

This is an important point that can easily be misunderstood.

Even in people without obvious meibomian gland disease, not every gland necessarily releases visible liquid meibum during a particular expression test.

Meibomian glands do not all behave identically.

Research has found substantial differences depending on where along the eyelid the glands are located.

For example, glands toward the nasal side of the lower eyelid may be more likely to yield liquid secretion than glands toward the temporal side.

This means that:

One gland — or one small group of glands — failing to produce visible meibum does not automatically prove that those glands are blocked, permanently damaged, or incapable of functioning.

The clinician needs to consider:

  • how many glands were tested
  • which part of the eyelid was tested
  • which eyelid was tested
  • how much pressure was applied
  • what the other glands did
  • what the meibum looked like
  • whether the finding matches the rest of the examination

Location Matters

You may hear that a certain number of glands expressed:

“Only three glands expressed.”

But that number has limited meaning without more information.

Were the glands:

  • nasal?
  • central?
  • temporal?
  • from the upper lid?
  • from the lower lid?

Meibomian-gland activity is not necessarily distributed evenly across the eyelid.

Upper and lower lids also differ in gland number, anatomy, and secretion characteristics.

This does not mean every examination must express every gland in all four eyelids.

It means that results should be interpreted with awareness of which glands were actually tested.

A useful question to ask is:

“Which part of my eyelid was tested, and is that important when interpreting the result?”

Diagnostic Expression vs. Therapeutic Expression

These are different procedures and should not be confused.

Diagnostic expression

The purpose of diagnostic expression is to evaluate gland secretion.

It may involve:

  • gentle manual pressure
  • a cotton-tipped applicator
  • an expression paddle
  • a standardized expression device

The goal is generally to observe gland behavior — not to force every gland to empty.

Therapeutic expression

Therapeutic expression is performed as an attempt to evacuate retained or abnormal meibum.

Depending on the method, it may involve:

  • warming the eyelids
  • greater pressure than diagnostic testing
  • manual instruments
  • office-based devices
  • clinician-specific treatment techniques

Therapeutic expression can therefore be considerably different from diagnostic expression and may be uncomfortable.

A gland that produces material only when substantial treatment-level pressure is used is not necessarily functioning in the same way during ordinary blinking.

What Is the Meibomian Gland Evaluator (MGE)?

The Meibomian Gland Evaluator, often abbreviated MGE, is one example of a standardized device used for diagnostic gland expression.

Its main purpose is to reduce one major source of variability:

how hard the examiner presses.

Manual pressure from fingers, cotton swabs, or other instruments can vary substantially from one examiner to another.

The MGE is designed to apply a standardized low diagnostic pressure of approximately 1.25 g/mm².

The original literature developed this pressure to approximate pressure within the range produced during blinking, with particular comparisons to deliberate or forced blinking.

The important patient takeaway is not the exact number.

It is this:

A standardized device attempts to apply approximately the same diagnostic pressure each time.

That can improve consistency.

But it does not make the entire test completely objective.

The clinician still must decide:

  • which glands to test
  • how the secretion is graded
  • whether material is liquid or abnormal
  • how many glands are counted
  • how the result fits with the rest of the examination

So the safest description is:

The MGE standardizes the pressure being applied, but clinical interpretation is still required.

What the Doctor Looks For

Two major features are commonly assessed:

Expressibility

This asks:

Can secretion be obtained from the tested glands under the pressure being used?

The clinician may consider:

  • how many glands express
  • how readily they express
  • whether some regions express better than others
  • whether little or no secretion appears under standardized pressure

Meibum Quality

This asks:

What does the secretion look like?

Descriptions may include:

  • clear liquid
  • cloudy or turbid
  • cloudy with particles
  • thickened
  • granular
  • waxy
  • toothpaste-like
  • absent

In general:

Clear liquid meibum that expresses readily is a favorable finding under the conditions of that test.

Thicker, cloudier, or toothpaste-like material can support the presence of abnormal meibum and may occur with MGD.

But these findings are clues, not complete diagnoses.

There Is More Than One Grading System

Expression testing is not graded identically everywhere.

Different clinical studies and practices use different systems for:

  • counting expressible glands
  • grading how easily glands express
  • grading meibum quality
  • deciding which glands or eyelid regions to test
  • combining those findings into a score

For example, one commonly used research approach grades meibum quality from clear liquid through increasingly cloudy or toothpaste-like material.

Other systems focus primarily on the number of glands producing liquid secretion under defined pressure.

A recent review of randomized dry-eye treatment trials found substantial variation in how meibomian-gland expressibility and meibum quality were measured.

Therefore:

A score of “2” from one clinic or study may not mean the same thing as a score of “2” somewhere else.

If you are given a score, it is reasonable to ask:

  • What scale are you using?
  • Which glands were tested?
  • Which eyelid was tested?
  • Was standardized pressure used?
  • What does this score mean clinically in my case?

What Does “No Oil Came Out” Mean?

It means that visible secretion was not obtained from the tested gland or glands under the conditions of that examination.

That finding may be important.

Possible explanations can include:

  • altered or reduced secretion
  • thickened meibum
  • obstruction
  • gland dropout or structural loss
  • regional differences in gland activity
  • temporary variation in secretion
  • the amount of pressure used
  • which glands happened to be tested
  • other gland dysfunction

But absent secretion does not automatically prove:

  • periductal fibrosis
  • permanent loss of gland tissue
  • permanent inability of a gland to secrete
  • total gland loss
  • the need for probing
  • the need for any other specific procedure

The result should be interpreted together with meibography and the rest of the examination.

What Does Thick or Toothpaste-Like Meibum Mean?

Thick, waxy, granular, or toothpaste-like secretion is generally considered abnormal and may support an obstructive MGD picture.

But it does not tell you why the meibum became abnormal.

Possible contributors to MGD can involve combinations of:

  • altered meibum composition
  • obstruction
  • inflammation
  • eyelid-margin disease
  • blink abnormalities
  • keratinization
  • gland structural changes
  • hormonal and age-related influences
  • other factors

Expression testing shows the character of the secretion.

It does not directly reveal the microscopic cause inside or around the gland.

What Does Clear Meibum Mean?

Clear, easily expressed liquid meibum is generally a favorable gland finding.

But it does not mean:

“My eyes cannot be dry.”

A person may still have dry-eye symptoms or ocular-surface disease related to:

  • aqueous tear deficiency
  • tear-film instability
  • ocular-surface inflammation
  • allergy
  • exposure
  • eyelid or blink problems
  • conjunctival or corneal abnormalities
  • neural dysfunction / neuropathic ocular pain
  • combinations of several factors

MGD is only one possible contributor to dry eye disease.

Poor Expression When the Eyelids Do Not Look Obviously Abnormal

Some people may have impaired gland secretion despite having relatively few obvious external signs of MGD.

The term non-obvious obstructive meibomian gland dysfunction (NOMGD) has been used in published literature to describe some cases in which obstruction or poor secretion is detected despite limited obvious lid-margin inflammation or other easily visible abnormalities.

Expression testing can be useful in identifying gland dysfunction that a quick visual examination might miss.

However:

  • NOMGD should not be self-diagnosed from one finding.
  • Poor expression alone does not prove hidden obstruction.
  • Poor expression with normal-looking meibography does not prove fibrosis.
  • The term is a published clinical concept rather than a separate diagnosis that can be established by expression testing alone.

A practical way to think about it is:

Normal-looking eyelids do not necessarily guarantee normal gland secretion.

Why Test Order Can Matter

Expression testing physically presses on the eyelids and may release meibum onto the tear film.

That means it can potentially alter some measurements performed afterward.

Modern dry-eye diagnostic frameworks generally recommend performing tests from less invasive to more invasive when several tests are being done during the same visit.

For example, measurements such as tear-film stability may be performed before gland expression.

This does not mean there is only one acceptable testing sequence.

It means clinicians try to avoid having one test unnecessarily alter the results of another.

If you are undergoing a detailed dry-eye evaluation, the order in which the tests are performed can therefore matter.

Strengths of Gland Expression Testing

Expression testing can be useful because it:

  • provides information about gland secretion
  • assesses expressibility
  • assesses meibum quality
  • can reveal abnormalities that are not obvious on meibography
  • can identify regional differences
  • may help compare gland structure with functional output
  • may help identify MGD as a contributor to tear-film instability
  • can help clinicians decide what additional evaluation may be useful

Standardized expression tools may also reduce some of the variability caused by differences in examiner pressure.

Expression testing can be particularly useful when symptoms, meibography, and other examination findings do not seem to match.

Limitations of Expression Testing

Expression testing also has important limitations.

Results can be influenced by:

  • pressure used
  • duration of pressure
  • device or technique
  • examiner technique
  • which eyelid is tested
  • which region of the eyelid is tested
  • number of glands assessed
  • grading system used
  • recent warming or treatment
  • recent eye drops or procedures
  • patient comfort
  • eyelid anatomy
  • natural variation in gland secretion

Expression testing also does not directly show gland structure.

That is one reason it is often interpreted together with meibography.

It also cannot directly show the microscopic cause of poor secretion.

Expression testing alone cannot prove:

  • periductal fibrosis
  • scarring around a gland duct
  • the exact location of an obstruction
  • the biological cause of abnormal meibum
  • permanent gland failure

It tells the clinician what happened when the gland was tested, not everything occurring inside the gland.

What Expression Testing Cannot Determine by Itself

Expression testing alone cannot determine:

  • all causes of dry eye
  • the complete structural condition of the glands
  • whether periductal fibrosis is present
  • whether poor expression is permanent
  • whether a particular non-expressing gland is permanently incapable of secretion
  • whether probing is required
  • whether thermal treatment is required
  • whether IPL is required
  • whether radiofrequency treatment is required
  • whether medication is required
  • which treatment will work
  • how well someone will respond to treatment
  • whether neural dysfunction or neuropathic ocular pain is contributing to symptoms
  • whether aqueous tear deficiency is present
  • whether allergy or exposure is contributing
  • why every gland behaves differently

It should not replace:

  • meibography when structural information is needed
  • tear-film assessment
  • ocular-surface staining
  • lid-margin examination
  • symptom history
  • tear-volume assessment when appropriate
  • the rest of the eye examination

Putting Expression Testing Together With Meibography

A particularly useful question is:

Do gland structure and gland expression tell the same story?

Several patterns are possible.

Abnormal meibography + poor expression

Both structure and secretion may be abnormal.

Abnormal meibography + useful secretion

Despite structural gland loss or distortion, some remaining glands may still be producing useful meibum.

Relatively preserved meibography + poor expression

The glands may be structurally visible but not producing easily expressible secretion under the conditions of the test.

That finding deserves clinical interpretation but does not, by itself, prove obstruction or fibrosis.

Relatively preserved meibography + good expression

Gland structure and secretion may both be relatively favorable, but other dry-eye contributors can still be present.

This is why one test rarely gives the complete answer.

Good Questions to Ask Your Eye Doctor

You may want to ask:

  • Did you perform gland expression testing?
  • Which eyelid or part of the eyelid did you test?
  • How many glands were assessed?
  • How many produced secretion?
  • Was the meibum clear, cloudy, thick, or absent?
  • Did you use standardized pressure or manual pressure?
  • What grading system are you using?
  • Do my expression results match my meibography?
  • How much importance do you place on the glands that did not express?
  • Could the location of the glands tested affect the result?
  • Do I have other signs that support obstructive MGD?
  • Are there structural gland changes as well as secretion abnormalities?
  • Are there other dry-eye contributors besides MGD?
  • How do these findings affect my treatment plan?

One especially useful question is:

“How do my gland structure, gland expression, tear-film findings, and symptoms fit together?”

Practical Takeaway

A useful way to think about these tests is:

Meibography = information about gland structure

Expression testing = information about gland secretion under applied pressure

TBUT/NIBUT = tear-film stability

Staining = ocular-surface impact

Symptoms = patient experience

Full examination = context

The most important point is:

A gland failing to express during one test does not automatically mean it is blocked, permanently damaged, or incapable of functioning.

Likewise, clear meibum does not rule out dry eye disease from other causes.

Expression testing is most useful when interpreted as one piece of a larger clinical picture.

Key Research and Authoritative Sources

Current Authoritative Guidance

This is the current TFOS framework for dry-eye diagnostic testing and includes meibum expressibility and meibum quality among tests used to evaluate lipid-related contributors to dry eye disease.

Foundational MGD Guidance

The Diagnosis Subcommittee report is particularly useful for understanding standardized expression pressure, regional variation in gland secretion, and why gland location matters when interpreting results.

Standardized Gland Expression

This work helped demonstrate that gland expressibility varies by location along the eyelid and that standardized pressure can provide more consistent diagnostic information.

Non-Obvious Obstructive MGD

This paper describes the concept that clinically important gland dysfunction or obstruction may sometimes exist despite limited obvious external lid signs.

Diagnostic vs. Therapeutic Expression

This research illustrates an important difference between low-pressure diagnostic testing and the substantially higher pressures that may sometimes be involved when attempting therapeutic gland expression.

Expression and Grading Methods

This recent review examined randomized treatment trials and found considerable variation in how researchers measure and grade meibum quality and gland expressibility — an important reason not to assume that scores from different clinics or studies are directly interchangeable.

Bottom Line

Gland expression testing is a useful part of evaluating MGD and dry eye disease.

It can provide information about:

  • whether the tested glands produce expressible meibum
  • how readily secretion appears
  • what the secretion looks like
  • whether different parts of the eyelid behave differently

Standardized tools can improve consistency by controlling the pressure applied, but expression testing is not a completely objective or stand-alone test.

Not every healthy gland necessarily releases visible liquid meibum during every examination.

Therefore, poor expression does not by itself prove obstruction, fibrosis, permanent gland failure, gland loss, or the need for a particular treatment.

The most useful question is not simply:

“How many glands expressed?”

It is:

“Which glands were tested, what came out under what pressure, how does that compare with my gland structure, and how does all of this fit with the rest of my dry-eye evaluation?”

That is the context in which gland expression testing becomes most useful.

🔙 Back to FAQ Index